TY  - JOUR 
AU  - Wang, Yu-Hung
AU  - Wei, Chao-Hung
AU  - Lin, Chien-Chin
AU  - Gurnari, Carmelo
AU  - Awada, Hussein
AU  - Benajiba, Lina
AU  - Daltro de Oliveira, Rafael
AU  - Soret-Dulphy, Juliette
AU  - Cassinat, Bruno
AU  - Zucenka, Andrius
AU  - Mosquera Orgueira, Adrián
AU  - Yuan, Chang-Tsu
AU  - Lee, Sze-Hwei
AU  - Yao, Chi-Yuan
AU  - Gurashi, Kristian
AU  - Hou, Hsin-An
AU  - Batta, Kiran
AU  - Pérez Encinas, Manuel Mateo
AU  - Chou, Wen-Chien
AU  - Maciejewski, Jaroslaw P
AU  - Wiseman, Daniel H
AU  - Kiladjian, Jean-Jacques
AU  - Tien, Hwei-Fang
PY  - 2025
UR  - http://hdl.handle.net/20.500.11940/22278
AB  - [EN] In addition to high-molecular risk (HMR) mutations (ASXL1, EZH2, SRSF2, IDH, and U2AF1Q157), lower JAK2V617F variant allele frequencies (VAF) have been demonstrated to be associated with poor prognosis of myelofibrosis (MF) patients....
LA  - eng
KW  - Prognosis
KW  - Mutation
KW  - Primary Myelofibrosis
KW  - High-Throughput Nucleotide Sequencing
KW  - Myeloproliferative Disorders
KW  - Gene Frequency
KW  - Janus Kinase 2
KW  - Survival Rate
TI  - Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study
DO  - 10.1038/s41375-024-02422-4
T2  - Leukemia
M2  - 144
KW  - CHUS
KW  - IDIS
VL  - 39
ER  -